JasonRossSchwartzMDPhD

Pediatric Hematologic Oncology

Physician

Dr. Schwartz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

Overexpression of human SAMD9 inhibits protein translation and alters MYC signaling resulting in cell cycle arrest.
Kristen McSweeney, Paul Hoover, Marisol Ramirez-Solano, Qi Liu, Jason R Schwartz
Experimental Hematology. 2024-09-01
7 citations
Mutant Samd9l expression impairs hematopoiesis and induces bone marrow failure in mice.
Sherif Abdelhamed, Melvin E Thomas 3rd, Tamara Westover, Masayuki Umeda, Emily Xiong
The Journal of Clinical Investigation. 2022-11-01
30 citations
Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.
Melvin Edward Thomas, Sherif Abdelhamed, Ryan Hiltenbrand, Jason R. Schwartz, Sadie Miki Sakurada
Leukemia. 2021-03-17

Lectures

Comprehensive Genomic Profiling of Pediatric Therapy-Related Myeloid Neoplasms Identifies Mecom Dysregulation to be Associated with Poor Outcome
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

CDC Panel Recommends Pfizer Boosters for Older and Some Higher-Risk Americans, with Agency Expected to Accept RecommendationSeptember 24th, 2021
Some States Allow Teen Vaccinations Without Parent’s OK. One Official Says She Was Fired for Sharing ThatJuly 13th, 2021

Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutationsVANDERBILT UNIVERSITY MEDICAL CENTER2020–2025